Navigating Pediatric Trials from recruitment to successful on-time completion

Instructor: Charles H Pierce
Product ID: 701675
  • Duration: 74 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

In this Pediatric Trials training learn how to evaluate the current issues and best practices in pediatric drug development, clinical investigation of medicinal products and non clinical evaluation of pediatric drug products.

Why Should You Attend:

Drug companies face many challenges in pediatric clinical research. Pediatric trials come with a high level of complexity and cost. In order for professionals to carry out a successful pediatric drug development plan, they need the right infrastructure and information to avoid obstacles such as slow recruitment, noncompliance and difficulties in developing the right study criteria and protocol. When conducting research on children, drug companies must ensure that ethical boundaries are observed in both the design and execution of pediatric trials.

Attend this Webinar to understand the ethical, economic, regulatory and technical considerations when conducting clinical studies on children. Discussions evaluate the current issues in pediatric drug development and discuss approaches and best practices for overcoming these challenges.

Areas Covered in the Seminar:

  • Compilation of various regulatory and guidance documents from the FDA and OHRP on the conduct of research involving children.
  • Recent guidances on compliance and general considerations in the conduct of research on children.
  • General Considerations for the Clinical Evaluation of Drugs in Infants and Children.
  • Discuss Clinical Investigation of Medicinal Products in the Pediatric Population.
  • Nonclinical Evaluation of Pediatric Drug Products.

Who Will Benefit:

This webinar will provide valuable assistance to all personnel in: Pharmaceutical, Biotechnology, CROs and Research Facilities Conducting Clinical Trials including:

  • Pediatric Affairs
  • Pediatric Strategy
  • Pediatrics
  • Clinical Research
  • Clinical Development
  • Clinical Operations
  • Clinical Affairs
  • Medical Affairs
  • Clinical Trial Management
  • Clinical Project
  • Regulatory
  • R&D
  • R&D Operations
  • Drug Development
  • Non-Clinical

Instructor Profile

Charles H. Pierce, MD, PhD, FCP, CPI Has 20+ years experience in bringing the message (via webinars, lectures and seminars) of Risk Management through knowledge of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects. He has been involved in developing Phase I & IIa Clinical Pharmacology Units, Investigator and staff GCP training, and medical monitoring in both drug and device studies.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed